Interferon-γ counteracts reduced endotoxin responsiveness of whole blood following trauma and cardiopulmonary bypass

Journal of Endotoxin Research

Volumn 6, Issue 6, 2000, Pages 431-436

  Flohe S ^a   Borgermann J ^a   Lim, L ^a   Schade, F U ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; ENDOTOXIN; GAMMA INTERFERON; HEPARIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD; BLOOD CULTURE; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HEART SURGERY; HUMAN; IMMUNE RESPONSE; IMMUNOSTIMULATION; IN VITRO STUDY; INFECTION COMPLICATION; INJURY; MALE; SURGICAL INJURY;

ADJUVANTS, IMMUNOLOGIC; ADULT; CARDIOPULMONARY BYPASS; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFLAMMATION; INTERFERON-GAMMA, RECOMBINANT; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA; WOUNDS AND INJURIES;

BACTERIA (MICROORGANISMS);

EID: 0034446881     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1179/096805100101532388     Document Type: Article

References (47)

1. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: What we do and do not know about cytokine regulation
2. Role of cytokines in sepsis
3. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial
4. Treatment of septic shock with the tumor necrosis factor/Fc fusion protein
5. Mice deficient for the 55 kDa tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection
6. Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice
7. Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: Priming for IL-12 and tumor necrosis factor α production
8. 2
9. IL-10 inhibits cytokine production by activated macrophages
10. Interleukin-10 release related to cardiopulmonary bypass in infants undergoing cardiac operations
11. Plasma levels of immunoinhibitory cytokines interleukin-10 and transforming growth factor-beta in patients undergoing coronary artery bypass grafting
12. Interleukin-10 is associated with the development of sepsis in trauma patients
13. Hyperstimulation of leukocytes by plasma from cardiopulmonary bypass patients is diminished by morphine and IL-10 pretreatment
14. Major injury induces increased production of interleukin-10 by cells of the immune system with a negative impact on resistance to infection
15. Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock
16. Depressed interferon gamma production and monocyte HLA-DR expression after severe injury
17. Response of the cellular immune system to cardiopulmonary bypass in vivo
18. Endotoxin tolerance after severe injury and its regulatory mechanisms
19. Regulation of whole blood tumor necrosis factor production upon endotoxin stimulation after severe blunt trauma
20. Distinct mechanisms of immunosuppression as a consequence of major surgery
21. Proinflammatory cytokine gene expression in whole blood from patients undergoing coronary artery bypass surgery and its modulation by pentoxifylline
22. In vitro cytokine production and T-cell proliferation in patients undergoing cardiopulmonary by-pass
23. IFN-gamma priming of monocytes enhances LPS-induced TNF production by augmenting both transcription and mRNA stability
24. Interferon-gamma treatment increases HLA-DR expression on monocytes in severely injured patients
25. Interferon-gamma: Biology and role in pathogenesis
26. The Injury Severity Score: A method for describing patients with multiple injuries and evaluating emergency care
27. Dynamics of interleukins 1, 2, and 6 and tumor necrosis factor alpha in multiple trauma patients
28. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma. Relation with subsequent adult respiratory distress syndrome and multiple organ failure
29. Elevated IL-8 production by trauma patients' monocytes is associated with elevated secretion of TNF alpha
30. Association of interleukin-4 plasma levels with traumatic injury and clinical course
31. Release of anti-inflammatory mediators after mechanical trauma correlates with severity of injury and clinical outcome
32. Relationship of interleukin-10 plasma levels to severity of injury and clinical outcome in injured patients
33. The release of transforming growth factor-beta following haemorrhage: Its role as a mediator of host immunosuppression
34. 2)-dependent suppression of interleukin alpha (IL-2) production in patients with major trauma
35. Successful restoration of cell-mediated immune response after cardiopulmonary bypass by immunomodulation
36. Terminal B-cell maturation and immunoglobulin (Ig) synthesis in vitro in patients with major injury
37. Reduced tumor necrosis factor production in endotoxin-spiked whole blood after trauma: Experimental results and clinical correlation
38. Tumor necrosis factor-α production in whole blood after cardiopulmonary bypass. Down-regulation caused by circulating cytokine-inhibitory activity
39. Priming of human monocytes for enhanced lipopolysaccharide responses: Expression of alpha interferon, interferon regulatory factors, and tumor necrosis factor
40. A randomized prospective clinical trial to determine the efficacy of interferon-gamma in severely injured patients
41. Interferon gamma in trauma-related infections
42. Interferon gamma administration increases monocyte HLA-DR antigen expression but not endogenous interferon production
43. Monocyte deactivation in septic patients: Restoration by IFN-gamma treatment
44. Inhibition of the defense system stimulating interleukin-12 interferon-gamma pathway during critical illness
45. Interferon gamma increases sensitivity to endotoxin
46. Molecular markers of hemostatic activation and inflammation following major injury: Effect of therapy with IFN-gamma
47. Interferon therapy: Pharmacokinetic and pharmacological aspects